A team of experts compared rates of cirrhosis, cardiovascular disease and metabolic abnormalities between patients with fatty liver disease who were of normal weight and overweight or obese.
Laboratory research paves the way for a clinical trial to see if an FDA-approved drug used to prevent organ transplant rejection can work against these aggressive brain tumors.
Although additional policies are needed to relieve insulin’s financial burden, researchers find a national cost-sharing cap helps privately insured patients pay less out-of-pocket.
A tiny arms race playing out inside the gut could eventually offer a new way to treat out-of-balance microbiomes.
Rather than attacking cancer cells directly, new cell-model research probes weaknesses in pancreatic cancer’s interactions with other cells to obtain nutrients needed for tumor growth.